NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,125 filers reported holding NOVARTIS A G in Q2 2020. The put-call ratio across all filers is 0.55 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $681,005 | -0.4% | 6,658 | -1.8% | 0.81% | +0.5% |
Q2 2023 | $683,717 | -2.6% | 6,778 | -11.2% | 0.80% | -9.8% |
Q1 2023 | $701,911 | -3.3% | 7,632 | -4.6% | 0.89% | +8.0% |
Q4 2022 | $725,903 | +20.6% | 8,002 | +1.0% | 0.82% | +15.1% |
Q3 2022 | $602,000 | -20.8% | 7,926 | -11.9% | 0.72% | -14.8% |
Q2 2022 | $760,000 | -1.9% | 9,000 | +1.8% | 0.84% | +9.4% |
Q1 2022 | $775,000 | +5.9% | 8,837 | +5.6% | 0.77% | +2.8% |
Q4 2021 | $732,000 | +7.3% | 8,369 | +0.3% | 0.75% | -7.1% |
Q3 2021 | $682,000 | -10.3% | 8,347 | +0.1% | 0.81% | -14.3% |
Q2 2021 | $760,000 | +7.3% | 8,338 | +0.6% | 0.94% | +4.4% |
Q1 2021 | $708,000 | -48.3% | 8,286 | -42.9% | 0.90% | -6.1% |
Q4 2020 | $1,370,000 | +4.3% | 14,504 | -4.0% | 0.96% | -3.0% |
Q3 2020 | $1,313,000 | -1.7% | 15,103 | -1.2% | 0.99% | -10.3% |
Q2 2020 | $1,336,000 | – | 15,292 | – | 1.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MANAGED ASSET PORTFOLIOS, LLC | 332,962 | $27,452,000 | 7.32% |
Mawer Investment Management Ltd. | 7,721,327 | $636,623,000 | 5.86% |
Martin Investment Management, LLC | 133,246 | $10,986,000 | 5.56% |
SCHARF INVESTMENTS, LLC | 1,330,175 | $109,673,000 | 5.48% |
Hansberger Growth Investors, LP | 46,663 | $3,847,000 | 5.19% |
Bain Capital Public Equity Management II, LLC | 440,233 | $36,297,000 | 4.25% |
First Fiduciary Investment Counsel, Inc. | 187,633 | $15,470,000 | 4.10% |
GARLAND CAPITAL MANAGEMENT INC | 53,555 | $4,416,000 | 4.02% |
Lowell Blake & Associates Inc. | 37,219 | $3,069,000 | 3.94% |
PRENTISS SMITH & CO INC | 68,027 | $5,609,000 | 3.89% |